Lyra Therapeutics, Inc.LYRANASDAQ
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank0
Year-over-Year Change
Year-over-year book value per share growth
Latest
-303.56%
↓ 565% vs avg
Percentile
P0
Near historical low
Streak
1 qtr
Consecutive declineDecelerating
Average
65.23%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -303.56% |
| Q2 2025 | 1942.54% |
| Q1 2025 | -66.93% |
| Q4 2024 | -43.47% |
| Q3 2024 | -33.43% |
| Q2 2024 | -60.92% |
| Q1 2024 | -17.08% |
| Q4 2023 | -1.27% |
| Q3 2023 | -34.47% |
| Q2 2023 | 25.78% |
| Q1 2023 | -29.54% |
| Q4 2022 | 0.61% |
| Q3 2022 | -19.12% |
| Q2 2022 | 44.61% |
| Q1 2022 | -18.17% |
| Q4 2021 | -27.12% |
| Q3 2021 | -17.99% |
| Q2 2021 | -15.18% |
| Q1 2021 | -9.22% |
| Q4 2020 | -8.18% |
| Q3 2020 | -41.00% |
| Q2 2020 | 292.98% |
| Q1 2020 | 201.49% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |